Chemotherapeutically active maytansinoids from Trewia nudiflora
First Claim
Patent Images
1. A substantially pure compound selected from the group consisting of trewiasine, dehydrotrewiasine, and N-demethyltrewiasine, characterized by the formula ##STR6## wherein for trewiasine:
- R1 =--CH(CH3)2, R2 =--CH3, and R3 =--CH3 ;
wherein for dehydrotrewiasine;
R1 = ##STR7## R2 =--CH3, and R3 =--CH3 ; and
wherein for N-demethyltrewiasine;
R1 =--CH(CH3)2, R2 =--CH3, and R3 =--H.
1 Assignment
0 Petitions
Accused Products
Abstract
A novel group of maytansinoid compounds has been discovered in the seed tissue of Trewia nudiflora. They are represented by the general formula ##STR1## and are all characterized by a distinguishing methoxy group on the C-15 carbon. These isolates have proven to be effective in causing the remission of one or more types of malignancies.
-
Citations
8 Claims
-
1. A substantially pure compound selected from the group consisting of trewiasine, dehydrotrewiasine, and N-demethyltrewiasine, characterized by the formula ##STR6## wherein for trewiasine:
- R1 =--CH(CH3)2, R2 =--CH3, and R3 =--CH3 ;
wherein for dehydrotrewiasine; R1 = ##STR7## R2 =--CH3, and R3 =--CH3 ; and
wherein for N-demethyltrewiasine;R1 =--CH(CH3)2, R2 =--CH3, and R3 =--H. - View Dependent Claims (2, 3, 4)
- R1 =--CH(CH3)2, R2 =--CH3, and R3 =--CH3 ;
- 5. A chemotherapeutic composition suitable for the remission of leukemia comprising a pharmaceutically acceptable vehicle and an amount effective to promote said remission of a substantially pure compound selected from the group consisting of trewiasine, dehydrotrewiasine, and N-demethyltrewiasine.
Specification